U2Bio Co (XKRX:221800) Operating Cash Flow per Share : ₩-256.18 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Operating Cash Flow per Share?

U2Bio Co's operating cash flow per share for the six months ended in Dec. 2023 was ₩221.86. U2Bio Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-256.18.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of U2Bio Co was -141.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for U2Bio Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 9 years, U2Bio Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 173.10% per year. The lowest was -50.80% per year. And the median was 23.50% per year.

XKRX:221800's 3-Year OCF Growth Rate is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

U2Bio Co Operating Cash Flow per Share Historical Data

The historical data trend for U2Bio Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Operating Cash Flow per Share Chart

U2Bio Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-93.58

180.73

1,262.12

604.12

-249.18

U2Bio Co Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	134.93	469.17	-478.03	221.86

Competitive Comparison of U2Bio Co's Operating Cash Flow per Share

For the Diagnostics & Research subindustry, U2Bio Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U2Bio Co's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where U2Bio Co's Price-to-Operating-Cash-Flow falls into.

U2Bio Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

U2Bio Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-2554.6	/	10.252
	=	-249.18

U2Bio Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	2274.464	/	10.252
	=	221.86

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₩-256.18

U2Bio Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Basement 1, 68 Gumaro Songpagu, Seoul, KOR

Website

http://www.u2bio.co.kr

U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines